According to a recent market intelligence report, the global gout therapeutics market was valued at US$ 1874 Mn in 2018. … Keep Reading
Pollen might cause misery to millions with hayfever sniffles every spring and summer, but new research has revealed it could … Keep Reading
A large-scale study of proteomes, proteomics is now widely in use as an effective tool for protein level identification, and, … Keep Reading
As one of the latest advancements in genome editing, CRISPR-Cas9 has provided deep insights for geneticists and scientists who are … Keep Reading
Microencapsulation is an advanced delivery system which involves storage of particles of an active agent in a protective shell made … Keep Reading
The healthcare sector is seeing a sea change with the development of state-of-the-art technologies and manufacturing procedures. Recent trends in … Keep Reading
The rapid growth of Saudi Arabia’s pharmaceutical market will be placed under the spotlight at the forthcoming CPhI Middle East … Keep Reading
Oncimmune Holdings plc (AIM: ONC.L), a leading global immunodiagnostics group, welcomes the presentation of data today by Professor Frank Sullivan … Keep Reading
It is with great pleasure that Azelis announces the appointment of Ron Rosenberg as its Group Technical Innovation Director, effective … Keep Reading
According to a recent study, the genealogy products and services market is likely to be valued at over US$ 3 billion … Keep Reading
Vaporizer pens, better known as vape pens, are advertised as safer, healthier alternatives to classic cigarettes. Though just saying something … Keep Reading
According to an MIT survey, as of today, over 26 million people have already taken at-home DNA tests. This matters … Keep Reading
According to a newly released report publicized by MarketsandMarkets, medical waste management industry cost is likely to boost from $11.3 … Keep Reading
Amman — A new programme designed to advance pharmaceutical workforces in countries around the world was launched by the International Pharmaceutical … Keep Reading
According to the latest study, around 422 million people worldwide have diabetes. Doctors predict that this number will double by … Keep Reading
Have you ever had the thought that therapy isn’t for you? Or maybe you’ve had the belief that therapy is … Keep Reading
Buying health supplements on Amazon via reputable review websites such as https://healthenergyguru.com/ is be one of the best ways to … Keep Reading
Everyone wants their body to be in the best condition, and our focus often turns to exercise and diet. We … Keep Reading
The International Institute of Knowledge Management (TIIKM) takes the pleasure to invite you to the 5thInternational Conference on Public Health 2019 … Keep Reading
“International Conference on Clinical & Experimental Dermatology” going to be held during December 05-06,2018 at Dubai,UAE. The conference is organized … Keep Reading
4th International Cancer Study & Therapy Conference aim is to emphasize scientific and academic activities towards the advances made in … Keep Reading
We are now in a connected age. Access to healthcare information is now widely available and this has drastically influence … Keep Reading
According to a recent market intelligence report, the global gout therapeutics market was valued at US$ 1874 Mn in 2018. It is projected to expand at a CAGR of 8.3% from 2019 to 2027. Rise in prevalence of gout arthritis across the globe is anticipated to boost the global gout therapeutics market during the forecast period. According to National Health and Nutrition Examination Survey (NHANES), prevalence among adults is estimated to be 3.9%, while 8.3 million people in the U.S.…
The rapid growth of Saudi Arabia’s pharmaceutical market will be placed under the spotlight at the forthcoming CPhI Middle East and Africa event, as the latest industry data reveals the Kingdom’s pharmaceutical market is expected to be valued at $10.74 billion (SR40.1 billion) by 2023. The event, sponsored by the Ministry of Health and Prevention (MoHaP), returns to the Abu Dhabi National Exhibition Center (ADNEC) from Sept. 16-18 and will explore the rapid reform of the country’s healthcare system at…
Oncimmune Holdings plc (AIM: ONC.L), a leading global immunodiagnostics group, welcomes the presentation of data today by Professor Frank Sullivan (Chief Investigator on the ECLS trial) which has demonstrated the potential of Oncimmune’s EarlyCDT® Lung test to reduce the incidence of patients with late-stage lung cancer at diagnosis, compared with standard clinical diagnosis. In a randomised controlled trial of 12,209 people in Scotland at high risk of developing lung cancer, it was shown that more people were diagnosed at an…